XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Earning before tax | ---- | -155.25%-132.7M | -125.81%-75.41M | ---- | -451.55%-15.31M | 26.40%-51.99M | ---33.39M | ---2.78M | ---70.63M |
Profit adjustment | |||||||||
Interest (income) - adjustment | ---- | -23,040.00%-3.47M | -5,666.67%-692K | ---- | -500.00%-24K | -87.50%-15K | ---12K | ---4K | ---8K |
Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | 57.82%-62K | ---62K | ---- | ---147K |
Revaluation surplus: | ---- | --41.35M | ---- | ---- | ---- | ---- | ---- | ---30K | ---- |
-Other fair value changes | ---- | --41.35M | ---- | ---- | ---- | ---- | ---- | ---30K | ---- |
Depreciation and amortization: | ---- | -1.91%8.64M | 0.43%6.48M | ---- | 0.41%2.21M | 45.08%8.81M | --6.45M | --2.2M | --6.07M |
-Depreciation | ---- | -3.03%6.4M | 0.21%4.8M | ---- | 0.55%1.66M | 174.85%6.6M | --4.79M | --1.65M | --2.4M |
Financial expense | ---- | -86.36%692K | -87.19%477K | ---- | -96.55%41K | 21.56%5.07M | --3.72M | --1.19M | --4.17M |
Exchange Loss (gain) | ---- | 30,803.70%8.29M | 16,336.36%5.36M | ---- | 300.00%4K | -1,000.00%-27K | ---33K | --1K | --3K |
Special items | ---- | 1,375.28%30.08M | 1,861.11%30.01M | ---- | -55.49%227K | -75.43%2.04M | --1.53M | --510K | --8.3M |
Operating profit before the change of operating capital | ---- | -30.28%-47.12M | -54.97%-33.78M | ---- | -1,281.43%-12.85M | 30.76%-36.17M | ---21.8M | --1.09M | ---52.24M |
Change of operating capital | |||||||||
Inventory (increase) decrease | ---- | -78.42%63K | 16.67%105K | ---- | 57.45%-454K | -40.41%292K | --90K | ---1.07M | --490K |
Accounts payable increase (decrease) | ---- | 744.85%9.33M | 248.47%7.88M | ---- | 218.51%6.83M | -211.05%-1.45M | ---5.31M | ---5.77M | --1.3M |
prepayments (increase)decrease | ---- | -206.68%-2.92M | -245.90%-4.91M | ---- | 102.42%87K | 224.21%2.74M | --3.37M | ---3.6M | ---2.21M |
Cash from business operations | ---- | -17.54%-40.65M | -29.81%-30.7M | ---- | 31.62%-6.39M | 34.31%-34.59M | ---23.65M | ---9.34M | ---52.65M |
Special items of business | -590.20%-120.2M | ---- | ---- | ---17.42M | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | -590.20%-120.2M | -17.54%-40.65M | -29.81%-30.7M | ---17.42M | 31.62%-6.39M | 34.31%-34.59M | ---23.65M | ---9.34M | ---52.65M |
Cash flow from investment activities | |||||||||
Interest received - investment | 11,425.00%2.77M | 18,180.00%2.74M | 5,666.67%692K | --24K | 500.00%24K | 87.50%15K | --12K | --4K | --8K |
Decrease in deposits (increase) | --35.41M | ---35.9M | ---35.9M | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | --721K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | -721.96%-5.13M | 28.42%-1.03M | 49.77%-647K | ---624K | -8.54%-89K | 73.91%-1.44M | ---1.29M | ---82K | ---5.52M |
Purchase of intangible assets | ---9.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5M |
Recovery of cash from investments | --51.71M | ---- | ---- | ---- | ---- | -43.76%17.56M | --17.56M | --11.52M | --31.23M |
Cash on investment | ---3.04M | -184.01%-49.7M | ---- | ---- | ---- | 43.69%-17.5M | ---17.5M | ---16.5M | ---31.08M |
Net cash from investment operations | 12,240.17%72.84M | -6,059.18%-83.89M | -2,853.38%-35.85M | ---600K | 98.72%-65K | 86.85%-1.36M | ---1.21M | ---5.06M | ---10.36M |
Net cash before financing | -162.88%-47.36M | -246.45%-124.54M | -167.66%-66.56M | ---18.02M | 55.20%-6.45M | 42.95%-35.95M | ---24.87M | ---14.41M | ---63.01M |
Cash flow from financing activities | |||||||||
New borrowing | 27.67%22.98M | -46.14%23M | -23.33%23M | --18M | -75.00%5M | -42.48%42.7M | --30M | --20M | --74.24M |
Refund | ---- | -127.97%-34.52M | ---- | ---- | ---- | -63.50%-15.14M | ---15.14M | ---11.74M | ---9.26M |
Issuing shares | --419.78M | --270.52M | --270.52M | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | -5,317.00%-24.21M | -663.60%-3.48M | ---- | ---447K | ---- | ---456K | ---- | ---- | ---- |
Adjustment item of financing business | ---- | ---- | ---3.21M | ---- | ---192K | ---- | ---- | ---- | ---- |
Net cash from financing operations | 2,270.91%416.17M | 842.65%255.5M | 1,853.59%290.3M | --17.55M | -41.79%4.81M | -58.29%27.1M | --14.86M | --8.26M | --64.98M |
Effect of rate | ---- | ---7.7M | ---5.38M | ---- | ---- | ---- | ---- | ---- | ---- |
Net Cash | 79,928.57%368.81M | 1,580.73%130.96M | 2,336.13%223.75M | ---462K | 73.22%-1.65M | -549.62%-8.84M | ---10.01M | ---6.15M | --1.97M |
Begining period cash | 6,768.42%125.07M | -82.93%1.82M | -82.93%1.82M | --1.82M | -82.93%1.82M | 22.61%10.67M | --10.67M | --10.67M | --8.7M |
Cash at the end | 36,241.57%493.88M | 6,768.42%125.07M | 33,312.75%220.19M | --1.36M | -96.13%175K | -82.93%1.82M | --659K | --4.52M | --10.67M |
Cash balance analysis | |||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.